Oncology News

New indication concerns a combination with pomalidomide and dexamethasone for the treatment of adult patients with relapsed and refractory multiple myeloma

Towards better understanding of the role of immune checkpoint inhibitors in the treatment of this population 

EU network takes steps to improve reporting and communication

Changes concern adoption of a new indication for gastric cancer and a change to the existing indication for colorectal cancer

New indications concern the first-line treatment of patients with metastatic non-squamous NSCLC who do not have EGFR mutated or ALK positive tumours,and those with extensive-stage SCLC

First ‘histology-independent’ treatment in the EU for solid tumours with a NTRK gene fusion

Greatest absolute benefit found in patients with stage III endometrial cancer or serous histology, or both

The results from KEYNOTE-183 study in patients with relapsed or refractory multiple myeloma

It was intended for the treatment of sickle cell disease

Identification of risk loci and a polygenic risk score for lung cancer in a large-scale prospective cohort study in Chinese populations

Results from a transcriptome-wide association study in over 140,000 European descendants

Collecting data for better representation of genetic variability